AmerisourceBergen Profit Margin 2006-2019 | ABC

Current and historical gross margin, operating margin and net profit margin for AmerisourceBergen (ABC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. AmerisourceBergen net profit margin as of June 30, 2019 is 0.54%.
AmerisourceBergen Annual Profit Margins
AmerisourceBergen Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $17.533B $167.940B
AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.377B 23.07
McKesson (MCK) United States $26.539B 10.25
Laboratory Of America Holdings (LH) United States $16.836B 15.94
Cooper (COO) United States $14.947B 25.29
Cardinal Health (CAH) United States $14.376B 9.13
Align Technology (ALGN) United States $14.175B 38.66
Straumann Holding AG (SAUHF) Switzerland $13.084B 0.00
DENTSPLY SIRONA (XRAY) United States $11.633B 24.59
West Pharmaceutical Services (WST) United States $10.635B 46.22
Henry Schein (HSIC) United States $9.536B 16.97
CONMED (CNMD) United States $2.860B 43.56
Patterson (PDCO) United States $1.743B 12.94
Merit Medical Systems (MMSI) United States $1.526B 15.90
Atrion (ATRI) United States $1.478B 41.12
STAAR Surgical (STAA) United States $1.301B 76.87
Antares Pharma (ATRS) United States $0.585B 0.00
Invacare (IVC) United States $0.261B 0.00
Lifevantage (LFVN) United States $0.185B 22.20
Endologix (ELGX) United States $0.078B 0.00
Pro-Dex (PDEX) United States $0.061B 19.47
Milestone Scientific (MLSS) United States $0.037B 0.00
Retractable Technologies (RVP) United States $0.029B 0.00
Biolase (BIOL) United States $0.023B 0.00